Neurobehavioural consequences of substance abuse and HIV infection

Journal of Psychopharmacology

Volumn 14, Issue 3, 2000, Pages 228-237

  Basso, Michael ^a   Bornstein, Robert A ^b  

^a UNIVERSITY OF TULSA   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

AIDS; Basal ganglia; Brain; Cocaine; Dementia; Dopamine; HIV; Methamphetamine; Neuroleptics; Opia tes; Parkinson's disease

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; OPIATE;

ARTICLE; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPATHOLOGY; INFECTION RATE; MORBIDITY; NEUROPATHOLOGY; PRIORITY JOURNAL; SUBSTANCE ABUSE;

EID: 0033746718     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110001400306     Document Type: Article

References (122)

1. Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients
2. High resolution brain SPECT imaging of marijuana smokers with AD/HD
3. Effect of substance abuse on visuographic function
4. Neuropsychological deficits in chronic cocaine abusers
5. Morphine-induced immune alterations in vivo
6. Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells
7. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS
8. Chronic amphetamine facilitates immunosuppression in response to a novel aversive stimulus: Reversal by haloperidol pretreatment
9. Effects of immunosuppression and disease severity upon neuropsychological function in HIV infection
10. Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12-months
11. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers
12. HIV dementia and the basal ganglia
13. Normalization of regional cerebral blood flow in alcoholics during the first 7 weeks of abstinence
14. Neuropsychological deficits in abstinent cocaine abusers: Preliminary findings after two weeks of abstinence
15. Effects of chronic marijuana use on human cognition
16. The neuropsychiatry of chronic cocaine abuse
17. Verbal learning and memory in alcohol abusers and polysubstance abusers with concurrent alcohol abuse
18. Rate of CD4 decline and neuropsychological performance in HIV infection
19. Neuropsychological performance in symptomatic and asymptomatic HIV infection
20. Duration of illness and neuropsychological performance in asymptomatic HIV infection
21. Cognitive loss and recovery in long-term alcohol abusers
22. Cerebral atrophy in young cannabis smokers
23. Central nervous system manifestations in human immunodeficiency virus infection without AIDS
24. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity
25. Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men
26. Alcohol abuse, alcoholism, and damage to the immune system - A review
27. Pathological regional cerebral blood flow in opiate-dependent patients during withdrawal: A HMPAO-SPECT study
28. Immunologic effects of cocaine and related alkaloids
29. Cognitive behavior in asymptomatic (CDC stage II and III) HIV-seropositive intravenous drug users (IVDUs)
30. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects
31. Premorbid brain size is a determinant of functional reserve in abstinent crack-cocaine and crack-cocaine-alcohol-dependent adults
32. Intravenous dextroamphetamine and brain glucose metabolism
33. Influence of heroin addiction on neuropsychological functioning
34. A mechanism of action for morphine-induced immunosuppression: Corticosterone mediates morphine-induced suppression of natural killer cell activity
35. Effects of amphetamine on T-cell immune response in mice
36. Neuropsychological efficiency measures in male and female alcoholics
37. Alterations of immune functions in heroin addicts and heroin withdrawal subjects
38. Human immunodeficiency virus-type 1 (HIV-1) and the brain
39. Neuropsychological effects of polydrug abuse
40. Evidence for early central nervous system ivolvemen in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections
41. Role of cannabinoid receptors in memory storage
42. Neurological and neuroradiological examination of chronic cannabis smokers
43. The HNRC 500 - Neuropsychology of HIV infection at different disease stages
44. Effects of crack cocaine on neurocognitive function
45. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats
46. Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging
47. Increased susceptibility of experimental animals to infectious organisms as a consequence of ethanol consumption
48. Dissociated effects of amphetamine on arousal and cortical blood flow in humans
49. Presentation of regional cerebral blood flow in amphetamine abusers by 99Tcm-HMPAO brain SPECT
50. Cocaine suppresses fetal immune system
51. Inhibition of natural killer cell function by marijuana components
52. Marijuana, immunity and infection
53. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse
54. Use of the Dementia Rating Scale as a test for neuropsychological dysfunction in HIV-positive i.v. drug abusers
55. The premature aging hypothesis: Old before its time?
56. Immune function in alcoholism: A controlled study
57. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double labeling immunohistochemical method
58. Marijuana, aging, and task difficulty effects on pilot performance
59. Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection
60. Detection of HIV in fetal central nervous system tissue
61. Speed of memory scanning is not affected in early HIV-1 infection
62. Substance abuse and cerebral blood flow
63. Regional cerebral blood flow after marijuana smoking
64. Acute changes in cerebral blood flow after smoking marijuana
65. Marijuana intoxication and brain activation in marijuana smokers
66. Neurological and neuropathological manifestations of HIV infection
67. Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. Multicenter AIDS Cohort Study
68. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
69. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35 428
70. Attention and memory in illicit amphetamine users
71. Attention and memory in illicit amphetamine users: Comparison with non-drug-using controls
72. Neurocognitive impairment: The unrecognized component of dual diagnosis in substance abuse treatment
73. Effects of chronic alcohol abuse and HIV infection on brain phosphorus metabolites
74. Parkinsonism with HIV infection
75. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia
76. The AIDS dementia complex: I. Clinical Features
77. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain
78. Effects of amphetamine on influenza virus infection in mice
79. Effects of amphetamine on cell mediated immune response in mice
80. The relationship between cognitive dysfunction and brain damage in alcoholics: Causal, interactive or epiphenomenal?
81. Neurobehavioral sequelae of alcoholism
82. Longterm neurological complications of chronic, habitual cocaine abuse
83. Cerebral atrophy in habitual cocaine abusers: A planimetric CT study
84. Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects
85. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta
86. Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements
87. Methamphetamine and HIV-1: Potential interactions and the use of the FIV/cat model
88. AIDS, drugs of abuse and the immune system: A complex immunotoxicological network
89. The residual cognitive effects of heavy marijuana use in college students
90. The residual neuropsychological effects of cannabis: The current status of research
91. Evidence for a sex-specific residual effect of cannabis on visuospatial memory
92. Cerebral perfusion in early and late opiate withdrawal: A technetium-99m-HMPAO SPECT study
93. Psychopathology in human immunodeficiency virus infection: Lifetime and current assessment
94. Neurobehavioral correlates of alcoholism
95. Opiates and immune function. Consequences on infectious diseases with special reference to AIDS
96. Morphine stimulates HIV replication in primary cultures of human Kupffer cells
97. Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
98. Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts
99. Cerebral perfusion and neuropsychological consequences of chronic cocaine use
100. Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication
101. Reversibility of alcohol-induced immune depression
102. Regional cerebral blood flow in long-term heavy cannabis use
103. Metacognition in HIV-1 seropositive asymptomatic individuals: Self-ratings versus objective neuropsychological performance
104. Declarative and procedural memory functioning in abstinent cocaine abusers
105. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: Evidence from [11C]WIN-35 428 positron emission tomography studies and direct in vitro determinations
106. Cerebral blood flow in chronic cocaine users: A study with positron emission tomography
107. Recovary of brain glucose metabolism in detoxified alcoholics
108. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET)
109. Acute cocaine effects on absolute cerebral blood flow
110. Alcohol consumption alters cytokine release during murine AIDS
111. Alcohol, immunomodulation, and disease
112. Neuropsychological impairment among intravenous drug users in pre-AIDS stages of HIV infection
113. The chronic cerebral effects of cannabis use. II. Psychological findings and conclusions
114. Human immunodeficiency virus within the brains of children with AIDS
115. Discussion: CT scan and neuropsychological assessments of alcoholism
116. AIDS, alcohol, endothelium, and immunity
117. Cocaine opens the blood-brain barrier to HIV-1 invasion